Victoria Skobel
Adult Health · Dallas, TXNPI 1770671307
Payments from drug & device makers
Across 222 payments — averaging $23.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$916
- Heartflow, Inc.$470
- Merck$382
- Pfizer$367
- Boehringer Ingelheim$310
- E.r. Squibb & Sons, L.L.C.$300
- plus $3K from 27 others
What the payments were for
- Food & beverage$5,10797%
- Education$1453%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 56 | $916 |
| Heartflow, Inc. | 12 | $470 |
| Merck | 21 | $382 |
| Pfizer | 17 | $367 |
| Boehringer Ingelheim | 14 | $310 |
| E.r. Squibb & Sons, L.L.C. | 12 | $300 |
| W. L. Gore & Associates, Inc. | 2 | $271 |
| Medtronic | 5 | $214 |
| Amgen | 10 | $180 |
| Esperion Therapeutics, Inc. | 9 | $178 |
| Johnson & Johnson | 10 | $178 |
| Astellas Pharma US Inc | 2 | $145 |
| Amarin Pharma, Inc. | 6 | $129 |
| Cardiovascular Systems Inc. | 1 | $126 |
| Endologix LLC | 2 | $115 |
| Boston Scientific | 4 | $113 |
| Lexicon Pharmaceuticals, Inc. | 5 | $109 |
| Abbott | 4 | $89 |
| AstraZeneca | 4 | $86 |
| Sanofi-aventis U.S. LLC | 4 | $78 |
| Tactile Systems Technology Inc | 5 | $72 |
| Cleerly, Inc. | 1 | $66 |
| Scpharmaceuticals Inc. | 3 | $57 |
| Impulse Dynamics (USA) Inc. | 2 | $50 |
| Philips North America LLC | 1 | $41 |
| Vital Connect, Inc | 2 | $41 |
| Silk Road Medical, Inc. | 1 | $35 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $33 |
| Bridgebio Pharma, Inc. | 1 | $25 |
| Biosense Webster, Inc. | 1 | $23 |
| Novo Nordisk | 1 | $23 |
| Irhythm Technologies, Inc. | 1 | $17 |
| Biotronik Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,252 in reported general payments places this provider in the 85th percentile of 933 adult health providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 47 | $46,764 |
| EntrestoSacubitril/Valsartan | 32 | $42,078 |
| XareltoRivaroxaban | 13 | $14,025 |
| FarxigaDapagliflozin Propanediol | 14 | $13,666 |
| JardianceEmpagliflozin | 15 | $8,706 |
| Propafenone Hcl ErPropafenone Hcl | 23 | $2,009 |
| Ranolazine ErRanolazine | 20 | $1,886 |
| Metoprolol Succinate | 99 | $1,326 |
| Losartan Potassium | 64 | $773 |
| Amlodipine Besylate | 94 | $762 |
| Cilostazol | 21 | $745 |
| Hydralazine Hcl | 52 | $573 |
| Atorvastatin Calcium | 28 | $515 |
| Valsartan | 12 | $420 |
| Rosuvastatin Calcium | 21 | $415 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $367 | $46,76447 claims |
| NovartisEntresto | $916 | $42,07832 claims |
| Johnson & JohnsonXarelto | $178 | $14,02513 claims |
| AstraZenecaFarxiga | $86 | $13,66614 claims |
| Boehringer IngelheimJardiance | $310 | $8,70615 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 933 adult health providers in Texas.
Other adult health in Dallas
- Melodie YoungDallas$700K
- Eric KlappholzDallas$44K
- Megan WheelerDallas$13K
- Joseph SchillDallas$7K
- Misty SheddAllen$863K
- Cynthia BedellPlano$168K
- Elizabeth Wedberg SivamAustin$71K
- Mary SalazarSan Antonio$68K
- Christin TouchetKingwood$43K
- Yulia LyuboslavskyAustin$36K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.